Amedisys, Inc. (NASDAQ:AMED) Stock Position Raised by Exchange Traded Concepts LLC

Exchange Traded Concepts LLC lifted its stake in shares of Amedisys, Inc. (NASDAQ:AMED) by 6.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,508 shares of the health services provider’s stock after acquiring an additional 450 shares during the quarter. Exchange Traded Concepts LLC’s holdings in Amedisys were worth $725,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Banque Cantonale Vaudoise bought a new stake in shares of Amedisys during the 1st quarter worth $60,000. Innealta Capital LLC bought a new stake in shares of Amedisys during the 2nd quarter worth $64,000. Covestor Ltd boosted its stake in shares of Amedisys by 134.2% during the 1st quarter. Covestor Ltd now owns 780 shares of the health services provider’s stock worth $72,000 after acquiring an additional 447 shares in the last quarter. Signaturefd LLC boosted its stake in shares of Amedisys by 88.2% during the 2nd quarter. Signaturefd LLC now owns 1,131 shares of the health services provider’s stock worth $104,000 after acquiring an additional 530 shares in the last quarter. Finally, CWM LLC boosted its stake in shares of Amedisys by 14.5% during the 3rd quarter. CWM LLC now owns 2,190 shares of the health services provider’s stock worth $211,000 after acquiring an additional 277 shares in the last quarter. 94.36% of the stock is owned by institutional investors.

Amedisys Price Performance

Shares of NASDAQ:AMED opened at $97.49 on Friday. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.30. Amedisys, Inc. has a 1 year low of $89.55 and a 1 year high of $98.95. The business has a fifty day simple moving average of $97.17 and a 200 day simple moving average of $95.35. The firm has a market cap of $3.19 billion, a price-to-earnings ratio of -152.33, a P/E/G ratio of 1.89 and a beta of 0.78.

Amedisys (NASDAQ:AMED) last announced its quarterly earnings data on Wednesday, July 24th. The health services provider reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.22 by $0.10. Amedisys had a return on equity of 12.39% and a net margin of 4.02%. The business had revenue of $591.19 million during the quarter, compared to analyst estimates of $579.34 million. As a group, sell-side analysts predict that Amedisys, Inc. will post 4.66 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on AMED shares. Cantor Fitzgerald restated a “neutral” rating and issued a $101.00 target price on shares of Amedisys in a report on Thursday, July 25th. William Blair lowered Amedisys from an “outperform” rating to a “market perform” rating in a report on Monday, July 1st. Finally, Deutsche Bank Aktiengesellschaft lowered Amedisys from a “buy” rating to a “hold” rating and set a $101.00 target price for the company. in a report on Monday, July 29th. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $100.67.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.